174 related articles for article (PubMed ID: 31813023)
81. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
Lin J; Johannsen E; Robertson E; Kieff E
J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
[TBL] [Abstract][Full Text] [Related]
82. EBNA2 and activated Notch induce expression of BATF.
Johansen LM; Deppmann CD; Erickson KD; Coffin WF; Thornton TM; Humphrey SE; Martin JM; Taparowsky EJ
J Virol; 2003 May; 77(10):6029-40. PubMed ID: 12719594
[TBL] [Abstract][Full Text] [Related]
83. Growth Transformation of B Cells by Epstein-Barr Virus Requires
Sugimoto A; Watanabe T; Matsuoka K; Okuno Y; Yanagi Y; Narita Y; Mabuchi S; Nobusue H; Sugihara E; Hirayama M; Ide T; Onouchi T; Sato Y; Kanda T; Saya H; Iwatani Y; Kimura H; Murata T
Microbiol Spectr; 2023 Aug; 11(4):e0044023. PubMed ID: 37409959
[TBL] [Abstract][Full Text] [Related]
84. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
[TBL] [Abstract][Full Text] [Related]
85. Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells.
Konforte D; Simard N; Paige CJ
Virology; 2008 Apr; 374(1):100-13. PubMed ID: 18222514
[TBL] [Abstract][Full Text] [Related]
86. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
[TBL] [Abstract][Full Text] [Related]
87. Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.
Ling PD; Peng RS; Nakajima A; Yu JH; Tan J; Moses SM; Yang WH; Zhao B; Kieff E; Bloch KD; Bloch DB
EMBO J; 2005 Oct; 24(20):3565-75. PubMed ID: 16177824
[TBL] [Abstract][Full Text] [Related]
88. Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs.
Canitano A; Venturi G; Borghi M; Ammendolia MG; Fais S
Cancer Lett; 2013 Sep; 337(2):193-9. PubMed ID: 23684926
[TBL] [Abstract][Full Text] [Related]
89. The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype.
Keane JT; Afrasiabi A; Schibeci SD; Swaminathan S; Parnell GP; Booth DR
EBioMedicine; 2021 Sep; 71():103572. PubMed ID: 34488019
[TBL] [Abstract][Full Text] [Related]
90. Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines.
Hui-Yuen J; McAllister S; Koganti S; Hill E; Bhaduri-McIntosh S
J Vis Exp; 2011 Nov; (57):. PubMed ID: 22090023
[TBL] [Abstract][Full Text] [Related]
91. Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.
Portal D; Zhou H; Zhao B; Kharchenko PV; Lowry E; Wong L; Quackenbush J; Holloway D; Jiang S; Lu Y; Kieff E
Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18537-42. PubMed ID: 24167291
[TBL] [Abstract][Full Text] [Related]
92. The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold.
Humme S; Reisbach G; Feederle R; Delecluse HJ; Bousset K; Hammerschmidt W; Schepers A
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10989-94. PubMed ID: 12947043
[TBL] [Abstract][Full Text] [Related]
93. CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell.
Hur DY; Lee MH; Kim JW; Kim JH; Shin YK; Rho JK; Kwack KB; Lee WJ; Han BG
Cell Prolif; 2005 Feb; 38(1):35-45. PubMed ID: 15679865
[TBL] [Abstract][Full Text] [Related]
94. The Epstein-Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization.
Wang J; Nagy N; Masucci MG
Oncogene; 2020 Jan; 39(3):603-616. PubMed ID: 31511648
[TBL] [Abstract][Full Text] [Related]
95. Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.
Wang LW; Shen H; Nobre L; Ersing I; Paulo JA; Trudeau S; Wang Z; Smith NA; Ma Y; Reinstadler B; Nomburg J; Sommermann T; Cahir-McFarland E; Gygi SP; Mootha VK; Weekes MP; Gewurz BE
Cell Metab; 2019 Sep; 30(3):539-555.e11. PubMed ID: 31257153
[TBL] [Abstract][Full Text] [Related]
96. The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth.
Ohashi M; Holthaus AM; Calderwood MA; Lai CY; Krastins B; Sarracino D; Johannsen E
PLoS Pathog; 2015 Apr; 11(4):e1004822. PubMed ID: 25855980
[TBL] [Abstract][Full Text] [Related]
97. Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes.
Ohashi M; Hayes M; McChesney K; Johannsen E
PLoS Pathog; 2021 Mar; 17(3):e1009419. PubMed ID: 33720992
[TBL] [Abstract][Full Text] [Related]
98. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.
Rasul E; Salamon D; Nagy N; Leveau B; Banati F; Szenthe K; Koroknai A; Minarovits J; Klein G; Klein E
PLoS One; 2014; 9(8):e106008. PubMed ID: 25162594
[TBL] [Abstract][Full Text] [Related]
99. MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival.
Forte E; Luftig MA
J Virol; 2009 Mar; 83(6):2491-9. PubMed ID: 19144715
[TBL] [Abstract][Full Text] [Related]
100. Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides.
De Francesco MA; Gargiulo F; Esteban P; Calzavara-Pinton PG; Venturini M; Perandin F; Baronio M; Pollara C; Terlenghi L; Manca N
J Med Microbiol; 2004 May; 53(Pt 5):381-387. PubMed ID: 15096546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
